Learn More
Medchemexpress LLC Gliclazide-d4 | 1185039-30-8 | 99.9% | 5 MG

Supplier: Medchemexpress LLC HYB0753S5MG
Gliclazide-d4 is the deuterium-labeled form of Gliclazide, an antidiabetic agent that functions as a whole-cell beta-cell ATP-sensitive potassium currents blocker with an IC50 of 184 nM. Deuteration, the process of incorporating stable heavy isotopes like hydrogen and carbon into drug molecules, is used for quantitation during drug development and has the potential to influence the pharmacokinetic and metabolic profiles of drugs.
- Can be used as a tracer.
- Can be used as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS.
- Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules.
- Largely used as tracers for quantitation during the drug development process.
- Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.